Estonian_biobank.jpg

Estonian Biobank

Restricted Access | Catalogue record last updated: 2026/04/27

The Estonian Biobank has established a population-based biobank of Estonia with a current cohort size of more than 200,000 individuals (genotyped with genome-wide arrays).


Scientific field(s): Genetics

The Estonian Biobank issues the following materials:
Data (descriptions of the state of health and lifestyle (phenotype data); genetic data)
Biological samples (DNA)
The Estonian Biobank database is regularly linked with national registries (such as Cancer Registry and Causes of Death Registry), hospital databases and the database of the national health insurance fund.

The sample size is the following:
Whole genome sequencing: 3 000.
Whole exome sequencing: 2 500.
Genome-wide genotyping arrays: 200 000.
Microbiome (Metagenomics): 2 509.
Genome-wide methylation arrays: 821.
Genome-wide expression arrays: 1 100.
mRNA sequencing: 600.
Total RNA sequencing: 50.
Metabolomics (NMR): 10 840.

Data processing level: Processed, Raw
Study design: Longitudinal
Method(s): Automated linkage, Genome-wide genotyping, Questionnaire, Whole-genome sequencing

Subjects were recruited randomly by general practitioners and physicians in hospitals.
Upon recruitment, all participants completed a questionnaire, including data about their health status, lifestyle and diet.
The genetic material of all Estonian Biobank participants has been genotyped using Illumina GSA microchip, which contains more than 700,000 SNP markers and includes specific variants of the Estonian population that allow an analysis of gene variants in the genome.

Associated ressources:
  • 10.1038/s41467-025-58465-3: Milani, L. et al. The Estonian Biobank’s journey from biobanking to personalized medicine. Nat. Commun. 16, 3270 (2025).
Catalogue record last updated: April 27, 2026, midnight